[Neuroprotective effect of Betoptic S-considerations after 18 months of treatment].

Abstract

BACKGROUND:

The aim of our study was the analysis of the hypotensor and neuroprotector effect induced by Betoptic S given to patients diagnosed with open-angled glaucoma.

MATERIALS AND METHODS:

A set of patients with open-angled glaucoma at different stages of evolution, during a period of 18 months were available for our examination. We took in to account parametres such as: ocular pressure values, fundus examination, kinetic and automatic perimetry.

RESULTS:

Betoptic S treatment in patients with open-angled glaucoma in early stages was efficient; therefore ocular pressure values continued in normal limits and visual capacity at automatic perimetry was improved. A number of patients in which Betoptic S didn't cause an ocular pressure compensation were given Xalatan. This association was a beneficial one. In those patients with open-angled glaucoma in terminal stage Betoptic S and Xalatan association was inefficient. In those patients which were not treated at all, visual capacity decreased to zero.

CONCLUSIONS:

1. Betoptic S neuroprotector effect is obvious in early glaucoma patients; visual capacity was improved in all cases. 2. In advanced and terminal stages of the disease visual capacity goes on decreasing in spite of the associated treatment.

• Authors: Florica Ignat, Carmen Damian, Rodica Mănescu, Ilia Perovic
• Journal: Oftalmologia (Bucharest, Romania : 1990) (Oftalmologia) Vol. 52 Issue 1 Pg. 75-80 ( 2002) ISSN: 1220-0875 [Print] Romania
• Vernacular Title: Efectul neuroprotector al tratamentului cu Betoptic S-consideraţii după 18 luni.
• PMID: 12677806 (Publication Type: English Abstract, Journal Article)

Chemical References

• Antihypertensive Agents
• Betaxolol

Topics

• Antihypertensive Agents (therapeutic use)
• Betaxolol (therapeutic use)
• Computer Graphics
• Glaucoma, Open-Angle (drug therapy)
• Humans
• Retrospective Studies
• Treatment Outcome